{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:01:54Z","timestamp":1791226914319,"version":"4.1.0"},"reference-count":102,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2023,2,1]]},"DOI":"10.1080\/13543784.2023.2178415","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T06:03:53Z","timestamp":1675836233000},"page":"127-139","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Investigational drugs for HIV: trends, opportunities and key players"],"prefix":"10.1080","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8984-0633","authenticated-orcid":false,"given":"Ronald J.","family":"Overmars","sequence":"first","affiliation":[{"name":"Viroscience Department, Erasmus Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8430-0411","authenticated-orcid":false,"given":"Zo\u00eb","family":"Krullaars","sequence":"additional","affiliation":[{"name":"Viroscience Department, Erasmus Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0515-9128","authenticated-orcid":false,"given":"Thibault","family":"Mespl\u00e8de","sequence":"additional","affiliation":[{"name":"Viroscience Department, Erasmus Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2021.1902504"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2018.1460357"},{"issue":"4","key":"cit0003","first-page":"396","volume":"84","author":"O\u2019Halloran JA","year":"2022","journal-title":"Clin Infect Dis"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2018.1560423"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkab481"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000713"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2443-1"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa060"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02057-20"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3503"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.67.1.1"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33662-6"},{"key":"cit0013","volume-title":"Pharmacokinetics of a simplified subcutaneous lenacapavir regimen versus Phase 2\/3 regimen","author":"Jogiraju V","year":"2022"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1038\/nature12162"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah5163"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2115542"},{"key":"cit0017","volume-title":"Efficacy and safety of long-acting subcutaneous lenacapavir in heavily treatment-experienced people with multi-drug resistant HIV: week 52 results","author":"Ogbuagu O","year":"2022"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab466.073"},{"key":"cit0019","volume-title":"Injection-site reaction experience in clinical studies of people using lenacapavir for HIV treatment","author":"Kumar P","year":"2022"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac492.1895"},{"key":"cit0021","unstructured":"Gupta SK, Sims J, Brinson C, et al. Lenacapavir as part of a combination regimen in treatment-naive people living with HIV: week 54 results. CROI 2022."},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04279-4"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0267780"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-16-8702-0_4"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000712"},{"key":"cit0026","first-page":"May","volume":"13","author":"Lai YT. Small Molecule HIV-1","year":"2021","journal-title":"Viruses"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1902493"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30240-X"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.33696\/AIDS.3.019"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01751-21"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12763"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac492.1095"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001058"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00409-12"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku451"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2120326119"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5255.1582"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2018.1430570"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1177\/1060028020942218"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.66.8.4784-4793.1992"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.149.5.1779"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1997.13.933"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1711460"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002591"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003218"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1126\/science.7973652"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000731"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28250-7"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac835"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04597-1"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04797-9"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02023-7"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34171-2"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01815-1"},{"key":"cit0055","unstructured":"Orkin C, Schapiro JM, Perno CF, et al. Expanded multivariable models to assist patient selection for long-acting cabotegravir + Rilpivirine treatment: clinical utility of a combination of patient, drug concentration, and viral factors associated with virologic failure over 152 weeks. HIV Glasgow 2022."},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-022-00608-1"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2022.2126310"},{"key":"cit0058","unstructured":"Borch J, Scherzer J, Jonsson-Oldenbuttel C, et al. 6-month outcomes of every 2 months long-acting cabotegravir and rilpivirine in a real-world setting - effectiveness, adherence to injections, and patient- reported outcomes of people living with HIV in the German CARLOS cohort. HIV Glasglow 2022."},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac631"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000733"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101016"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00538-4"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(22)00251-X"},{"issue":"2","key":"cit0064","first-page":"11","volume":"70","author":"Joob B","year":"2022","journal-title":"J Assoc Physicians India"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.7326\/M21-1548"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(21)00025-5"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245955"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab152"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac415"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-018-0440-3"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105427"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002883"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14081588"},{"key":"cit0074","volume-title":"Pharmacokinetics and tolerability of cabotegravir and rilpivirine long-acting intramuscular injections to the vastus lateralis (lateral thigh) muscles of healthy adult participants","author":"Han K","year":"2022"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000301"},{"issue":"22","key":"cit0076","first-page":"00365","volume":"2352","author":"Smith J","year":"2023","journal-title":"Lancet HIV"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1318249111"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003201"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002628"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-017-0370-5"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.68174"},{"key":"cit0082","author":"Ferrara M","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30902-7"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06490-w"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02885-x"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2020.100068"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120844"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25690-5"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(21)00300-3"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2011.613910"},{"key":"cit0091","first-page":"1","author":"Moffatt K","year":"2022","journal-title":"Pharm Res"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-249"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.18.1.20824"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1139\/cjm-2015-0725"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.3390\/v7072790"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.3390\/v6093377"},{"key":"cit0097","unstructured":"Leone P, Ferro A, Rolle CP, et al. VH3810109 (N6LS) reduces viremia across a range of doses in ART-naive adults living with HIV: proof of concept achieved in the Phase IIa BANNER (207959, NCT04871113) study. HIV Glasgow; 2022."},{"key":"cit0098","doi-asserted-by":"publisher","DOI":"10.20411\/pai.v1i1.104"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2011.0234"},{"key":"cit0100","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01189-18"},{"key":"cit0101","unstructured":"Vargo R, Robey S, Zang X, et al. Modeling and simulation to optimize islatravir Once Daily (QD) doses in HIV treatment naive and virologically suppressed populations. HIV Glasgow; 2022."},{"key":"cit0102","doi-asserted-by":"publisher","DOI":"10.1126\/science.add6502"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2023.2178415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T16:49:30Z","timestamp":1678121370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2023.2178415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":102,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2,1]]}},"alternative-id":["10.1080\/13543784.2023.2178415"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2023.2178415","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-11-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}